Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Protein Innovation (IPI) develops high-quality synthetic recombinant antibodies and other protein tools to accelerate biomedical research. It operates as a nonprofit, combining academic freedom with industrial-scale technology. IPI’s resources are widely shared through licensing and collaborations with both academic institutions and industry partners. The organization does not have its own clinical pipeline but supports the global scientific community in advancing therapeutic discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Protein Innovation.